搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 天
on MSN
U.S. Money Supply Recently Did Something Last Seen During the Great Depression -- and It's ...
Based on what 155 years of historic precedent tells us about notable declines in M2 and the performance of the U.S. economy ...
Verywell Health on MSN
4 小时
13 Natural Remedies and Alternative Therapies to Help Cope With Depression
Medically reviewed by Arno Kroner, DAOM Depression is a common but serious mental health disorder, affecting approximately 18.4% of adults in the United States. There are several natural remedies and ...
2 天
on MSN
Drinkers with depression experience same stimulation as those without depression: Study
The study by the University of Chicago Medicine in the US reveals that counter the long-held belief that the pleasure people ...
1 天
Are medical mushrooms the next frontier in anxiety and depression treatment? Some think so.
There is growing momentum to legalize certain psychedelics — namely psilocybin. That push is well underway in Nevada.
CNET on MSN
6 天
Feeling SAD? Expert Tips to Manage Your Seasonal Depression
If you have a history of depression or bipolar disorder, a healthy and active lifestyle is essential to minimizing the impact ...
US Weekly on MSN
1 天
Singer Michelle Williams Opens Up About Checking Herself Into Treatment for Depression in 2018
Destiny's Child alum Michelle Williams opened up about how leaving a Broadway show for depression treatment in 2018 led her ...
14 天
FDA approves standalone use of J&J's ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...
13 天
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
14 天
on MSN
US FDA approves J&J's ketamine-based therapy to treat depression
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...
14 天
US FDA approves standalone use of J&J’s ketamine-derived depression treatment
The US Food and Drug Administration (FDA) has expanded the approval for Johnson & Johnson’s nasal spray Spravato to allow its ...
10 天
Nasal Spray For Depression Now Has Approval Of US Govt
Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈